Stoke Therapeutics, Inc. Common Stock (STOK) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for STOK. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 189 institutions reported holding STOK, with 76.2 million shares worth $2.5 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 5,877,357 | $192M | INCREASED |
| Rtw Investments | 5,623,525 | $184M | UNCHANGED |
| FMR | 5,313,100 | $174M | DECREASED |
| T. Rowe Price | 5,076,878 | $166M | INCREASED |
| Lynx1 Capital Management | 4,038,404 | $132M | DECREASED |
Full institutional holdings, insider history, and congressional trades for Stoke Therapeutics, Inc. Common Stock on SentiSense.